2024-06-04
2024-03-17
November 21, 2024
At Crown Bioscience, our Patient-Derived Xenograft (PDX) Tumor Microarrays (TMAs) offer researchers a powerful tool for cancer research, enabling high-throughput analysis of various cancer types. Our PDX TMAs provide an extensive array of tissue samples crucial for biomarker validation, drug target discovery, and translational research.
For more information about our PDX TMAs or to discuss your research needs, please contact us.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy